JATT Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch JATT and buy or sell other stocks, ETFs, and their options commission-free!About JATT
Zura Bio Ltd. is a clinical-stage biotechnology company, which engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases.
CEOKimberly Ann Davis
CEOKimberly Ann Davis
Employees30
Employees30
HeadquartersHenderson, Nevada
HeadquartersHenderson, Nevada
Founded2022
Founded2022
Employees30
Employees30
JATT Key Statistics
Market cap241.87M
Market cap241.87M
Price-Earnings ratio-5.77
Price-Earnings ratio-5.77
Dividend yield—
Dividend yield—
Average volume538.57K
Average volume538.57K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.68
52 Week high$4.68
52 Week low$0.97
52 Week low$0.97
Stock Snapshot
With a market cap of 241.87M, JATT Acquisition(JATT) trades at $3.72. The stock has a price-to-earnings ratio of -5.77.
During the trading day, JATT Acquisition(JATT) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 538.57K.
Over the past 52 weeks, JATT Acquisition(JATT) stock has traded between a high of $4.68 and a low of $0.97.
Over the past 52 weeks, JATT Acquisition(JATT) stock has traded between a high of $4.68 and a low of $0.97.
People also own
Based on the portfolios of people who own JATT. This list is generated using Robinhood data, and it’s not a recommendation.